419 filings
Page 3 of 21
8-K
txvn0
9 Aug 16
Other Events
12:00am
8-K
e0dt51m5fa3t9zzu9d
19 Jul 16
Enclomiphene ( EnCyzix ™) A Mechanistically Consistent Approach to the Treatment of Secondary Hypogonadism
12:00am
8-K
ssva1snxbqz0qewlj15
1 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
anfi3tqmj66uoq
7 Jun 16
Regulation FD Disclosure
12:00am
8-K
i6aayi52tqr1tsb b5
1 Jun 16
Regulation FD Disclosure
12:00am
8-K
3rkfahsw2smggfyq
18 May 16
Repros Reports Positive Clinical Data for Oral Proellex® in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
12:00am
8-K
qhraewbpdtid ijx6t
16 May 16
Repros Announces the Appointment of MR. Patrick Fourteau As Chairman of the Board
12:00am
8-K
5x4e5aerxqo248p3rcv
10 May 16
Repros Therapeutics Inc.® Reports First Quarter 2016 Financial Results
12:00am
8-K
mkbo58 4st
12 Apr 16
Repros Reports Positive Clinical Data for Vaginal Proellex® in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
12:00am
8-K
m4z9gin
15 Mar 16
Repros Announces Initiation of Formal Approval Process by the European Medicines Agency
12:00am
8-K
tujjczhh ma6tg
14 Mar 16
Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2015 Financial Results
12:00am
8-K
8k48nsmo
16 Feb 16
Repros Completes Randomization of Enclomiphene Phase 2 Proof of Concept Study in Obese Secondary Hypogonadal Men
12:00am
8-K
1r4lg
8 Feb 16
Repros Holds Meeting With FDA to Discuss Complete Response Letter for Enclomiphene in the Treatment of Secondary Hypogonadism
12:00am
8-K
1n570
11 Jan 16
Repros Announces Court of Appeals’ Affirmation of Summary Judgment in Favor of the Company
12:00am
8-K
0iedfa3106q
6 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
a87h nbhj
4 Jan 16
Repros Updates Enclomiphene Program
12:00am
8-K
mcqboz3cgr1inrrnmu
21 Dec 15
Repros Updates Proellex® Program
12:00am
8-K
5vtfpe
1 Dec 15
Regulation FD Disclosure
12:00am
8-K
7kajrzuqxjtysuu 2do
17 Nov 15
Enclomiphene ( EnCyzix ™) A Mechanistically Consistent Approach to the Treatment of Secondary Hypogonadism
12:00am
8-K
n64vi00ykpnwlr0x0fwp
16 Nov 15
Departure of Directors or Certain Officers
12:00am